Related Experiment Video
Updated: Sep 26, 2026

Colony-Forming Unit Assay Adapted For Patient-Derived Bone Marrow and Peripheral Blood Mononuclear Cells
Published on: June 26, 2026
[Treatment of myeloproliferative diseases]
Vildan Bijedić1, Jasmina Berbić-Fazlagić, Aida Dizdarević
1Klinika za hematologiju, KCU u Sarajevu.
Abstract:
The modern treatment of the myeloproliferative disease is based on knowledge about pathogenic tumour's growing up and basically the treatment is based on the use of cytoxic therapy. The mix of cytotoxic is bringing up to the reducing of disease at the some percentages. Related the above disease in practice interferons showed themselves quite efficiently and in practice of allogenic transplantation of marrow bone is gave and a possibility of recovery of the chronic myeloid leukemia. The use of alias "the smart medicines" are made a blockade of transgenes signals and inhibiting induced pathologic coagulation of enzymes and responsible for a cell homeostasis (cell's growth) opened a new perspective in the treatment of malignant haematological diseases. The right direction of treatment' strategy for sure is bringing to the survival extension.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

